<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>PILMAN &#187; call</title>
	<atom:link href="http://www.tapanray.in/tag/call/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.tapanray.in</link>
	<description>A Tapan Ray Website</description>
	<lastBuildDate>Sun, 22 Mar 2026 10:59:18 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.4.2</generator>
		<item>
		<title>Arresting continuous job losses in the global pharma industry call for innovation across the value chain</title>
		<link>http://www.tapanray.in/arresting-continuous-job-losses-in-the-global-pharma-industry-call-for-innovation-across-the-value-chain/?utm_source=rss&#038;utm_medium=rss&#038;utm_campaign=arresting-continuous-job-losses-in-the-global-pharma-industry-call-for-innovation-across-the-value-chain</link>
		<comments>http://www.tapanray.in/arresting-continuous-job-losses-in-the-global-pharma-industry-call-for-innovation-across-the-value-chain/#comments</comments>
		<pubDate>Mon, 05 Mar 2012 00:00:09 +0000</pubDate>
		<dc:creator>Tapan Ray</dc:creator>
				<category><![CDATA[Pharma]]></category>
		<category><![CDATA[Across]]></category>
		<category><![CDATA[Arresting]]></category>
		<category><![CDATA[call]]></category>
		<category><![CDATA[chain]]></category>
		<category><![CDATA[continuous]]></category>
		<category><![CDATA[drugs]]></category>
		<category><![CDATA[for]]></category>
		<category><![CDATA[global]]></category>
		<category><![CDATA[in]]></category>
		<category><![CDATA[industry]]></category>
		<category><![CDATA[innovation]]></category>
		<category><![CDATA[job]]></category>
		<category><![CDATA[losses]]></category>
		<category><![CDATA[NCE]]></category>
		<category><![CDATA[NME]]></category>
		<category><![CDATA[Patent]]></category>
		<category><![CDATA[pharmaceutical]]></category>
		<category><![CDATA[R&D]]></category>
		<category><![CDATA[Ray]]></category>
		<category><![CDATA[Tapan]]></category>
		<category><![CDATA[technology]]></category>
		<category><![CDATA[the]]></category>
		<category><![CDATA[value]]></category>

		<guid isPermaLink="false">http://tapanray.in/index.php/?p=125</guid>
		<description><![CDATA[In not too distant past, the stocks of the global pharmaceutical companies, by and large, used to be categorized as ‘blue-chips’ for their high return to investors, as compared to many other sectors. Unfortunately, the situation has changed significantly since &#8230; <a href="http://www.tapanray.in/arresting-continuous-job-losses-in-the-global-pharma-industry-call-for-innovation-across-the-value-chain/">Continue reading <span class="meta-nav">&#8594;</span></a>]]></description>
		<wfw:commentRss>http://www.tapanray.in/arresting-continuous-job-losses-in-the-global-pharma-industry-call-for-innovation-across-the-value-chain/feed/</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
